Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy

Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy

Abstract Differential diagnosis between Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA) using cerebrospinal fluid (CSF) biomarkers is challenging. A recent study suggested that the addition of Aβ38 and Aβ43 to a standard AD biomarker panel (Aβ40, Aβ42, t‐tau, p‐tau) to improve th...

Full description

Bibliographic Details
Main Authors: Justina Dargvainiene, Ulf Jensen‐Kondering, Benjamin Bender, Daniela Berg, Norbert Brüggemann, Charlotte Flüh, Robert Markewitz, Alexander Neumann, Benjamin Röben, Christoph Röcken, Georg Royl, Claudia Schulte, Klaus‐Peter Wandinger, Caroline Weiler, Nils G. Margraf, Gregor Kuhlenbäumer
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51987

Internet

https://doi.org/10.1002/acn3.51987

Similar Items